Novo Integrated Sciences ROA 2012-2024 | NVOS
Current and historical return on assets (ROA) values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Novo Integrated Sciences ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-08-31 |
$-0.02B |
$0.03B |
-48.92% |
| 2024-05-31 |
$-0.03B |
$0.04B |
-69.93% |
| 2024-02-29 |
$-0.01B |
$0.04B |
-33.33% |
| 2023-11-30 |
$-0.01B |
$0.04B |
-38.62% |
| 2023-08-31 |
$-0.01B |
$0.04B |
-35.62% |
| 2023-05-31 |
$-0.03B |
$0.04B |
-84.77% |
| 2023-02-28 |
$-0.04B |
$0.04B |
-74.87% |
| 2022-11-30 |
$-0.04B |
$0.04B |
-63.35% |
| 2022-08-31 |
$-0.03B |
$0.04B |
-53.44% |
| 2022-05-31 |
$-0.01B |
$0.07B |
-19.40% |
| 2022-02-28 |
$-0.01B |
$0.07B |
-15.13% |
| 2021-11-30 |
$-0.01B |
$0.06B |
-9.85% |
| 2021-08-31 |
$0.00B |
$0.06B |
-9.20% |
| 2021-05-31 |
$-0.01B |
$0.04B |
-16.33% |
| 2021-02-28 |
$-0.01B |
$0.04B |
-16.90% |
| 2020-11-30 |
$-0.01B |
$0.04B |
-16.67% |
| 2020-08-31 |
$-0.01B |
$0.04B |
-14.18% |
| 2020-05-31 |
$0.00B |
$0.04B |
-2.90% |
| 2020-02-29 |
$0.00B |
$0.04B |
-3.01% |
| 2019-11-30 |
$0.00B |
$0.03B |
0.00% |
| 2019-08-31 |
$0.00B |
$0.03B |
0.00% |
| 2019-05-31 |
$0.00B |
$0.03B |
0.00% |
| 2019-02-28 |
$0.00B |
$0.03B |
0.00% |
| 2018-11-30 |
$0.00B |
$0.01B |
-20.00% |
| 2018-08-31 |
$0.00B |
$0.01B |
-20.00% |
| 2018-05-31 |
$0.00B |
$0.01B |
-19.05% |
| 2018-02-28 |
$0.00B |
$0.01B |
-19.05% |
| 2017-11-30 |
$0.00B |
$0.01B |
0.00% |
| 2017-08-31 |
$0.00B |
$0.01B |
0.00% |
| 2017-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2017-02-28 |
$0.00B |
$0.00B |
0.00% |
| 2016-11-30 |
$0.00B |
$0.00B |
0.00% |
| 2016-09-30 |
$0.00B |
$0.00B |
0.00% |
| 2016-05-31 |
$0.00B |
$0.00B |
0.00% |
| 2016-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2015-06-30 |
$0.00B |
$0.00B |
0.00% |
| 2015-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00% |
| 2014-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2013-09-30 |
$0.00B |
$0.00B |
0.00% |
| 2013-06-30 |
$0.00B |
$0.00B |
0.00% |
| 2012-12-31 |
$0.00B |
$0.00B |
0.00% |
| 2012-09-30 |
$0.00B |
$0.00B |
0.00% |
| 2012-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2012-02-29 |
$0.00B |
$0.00B |
0.00% |
| 2011-11-30 |
$0.00B |
$0.00B |
0.00% |
| 2011-09-30 |
$0.00B |
$0.00B |
0.00% |
| 2011-08-31 |
$0.00B |
$0.00B |
0.00% |
| 2011-06-30 |
$0.00B |
$0.00B |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
